NOT KNOWN FACTUAL STATEMENTS ABOUT HEMGENIX

Hemgenix is offered ‘conditional authorisation’. Therefore the eu Medicines Agency resolved that the benefits of Hemgenix are higher than its risks, but the corporation will have to provide more evidence just after authorisation.Professionals noted that the volume of patients anticipated to acquire etranacogene dezaparvovec in another three yea